About Epygen Biotech
Epygen Biotech is a company based in Mumbai (India) founded in 2016. The company has 47 employees as of April 08, 2024. Epygen Biotech offers products and services including Recombinant Streptokinase, Pegfilgrastim, Bevacizumab, Teriparatide, and SARS-CoV-2 Vaccine.
- Headquarter Mumbai, India
- Employees 47 as on 08 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Epygen Biotech Private Limited
- Date of Incorporation 25 Aug, 2011
- Jurisdiction Rasayani, Maharashtra, India
-
Annual Revenue
$911.35 K (USD)179.47as on Mar 31, 2023
-
Net Profit
-$200.41 K (USD)66.14as on Mar 31, 2023
-
EBITDA
$345.65 K (USD)135.77as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
47
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epygen Biotech
Epygen Biotech offers a comprehensive portfolio of products and services, including Recombinant Streptokinase, Pegfilgrastim, Bevacizumab, Teriparatide, and SARS-CoV-2 Vaccine.
Treats cardiovascular conditions using recombinant technology.
Supports oncology patients by boosting white blood cell production.
Targets tumors for oncology treatment applications.
Manages hormonal disorders through protein-based therapy.
Provides immunity against viral infections like COVID-19.
Offers contract development for biopharmaceutical production needs.
Funding Insights of Epygen Biotech
Detailed funding history for Epygen Biotech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epygen Biotech
Investment portfolio details for Epygen Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epygen Biotech
Detailed financials for Epygen Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epygen Biotech Comparisons
Peer comparison for Epygen Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epygen Biotech
Detailed competitors of Epygen Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epygen Biotech
Complete news archive for Epygen Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epygen Biotech
Epygen Biotech was founded in 2016.
Epygen Biotech is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Apr 08, 2024, the latest employee count at Epygen Biotech is 47.
Annual revenue of Epygen Biotech is $911.35K as on Mar 31, 2023.
Epygen Biotech was founded in 2016 in Mumbai, India, within the biotechnology sector. Recombinant enzymes, antibodies, and hormones are developed by the company for oncology, cardiovascular, and immune disorders. The lead candidate, recombinant streptokinase, is targeted at cardiovascular conditions. Additional candidates, such as Peg-filgrastim and Bevacizumab, address cancer treatment, while teriparatide is intended for osteoporosis in postmenopausal women. Operations focus on therapeutic protein development.
Epygen Biotech offers Recombinant Streptokinase, Pegfilgrastim, Bevacizumab, Teriparatide, and 2 more products and services.